List of Tables
Table 1. Global TYK2 Targeting Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global TYK2 Targeting Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global TYK2 Targeting Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global TYK2 Targeting Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global TYK2 Targeting Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global TYK2 Targeting Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global TYK2 Targeting Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market TYK2 Targeting Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of TYK2 Targeting Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of TYK2 Targeting Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of TYK2 Targeting Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of TYK2 Targeting Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global TYK2 Targeting Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on TYK2 Targeting Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global TYK2 Targeting Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global TYK2 Targeting Drugs Sales by Region (K Units), 2021–2026
Table 18. Global TYK2 Targeting Drugs Sales Market Share by Region (2021–2026)
Table 19. Global TYK2 Targeting Drugs Sales by Region (K Units), 2027–2032
Table 20. Global TYK2 Targeting Drugs Sales Market Share by Region (2027–2032)
Table 21. Global TYK2 Targeting Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global TYK2 Targeting Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global TYK2 Targeting Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global TYK2 Targeting Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America TYK2 Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America TYK2 Targeting Drugs Sales by Country (K Units), 2021–2026
Table 27. North America TYK2 Targeting Drugs Sales by Country (K Units), 2027–2032
Table 28. North America TYK2 Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America TYK2 Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe TYK2 Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe TYK2 Targeting Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe TYK2 Targeting Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe TYK2 Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe TYK2 Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific TYK2 Targeting Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific TYK2 Targeting Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific TYK2 Targeting Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific TYK2 Targeting Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific TYK2 Targeting Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America TYK2 Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America TYK2 Targeting Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America TYK2 Targeting Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America TYK2 Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America TYK2 Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa TYK2 Targeting Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa TYK2 Targeting Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa TYK2 Targeting Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa TYK2 Targeting Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa TYK2 Targeting Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global TYK2 Targeting Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global TYK2 Targeting Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global TYK2 Targeting Drugs Sales Market Share by Type (2021–2026)
Table 53. Global TYK2 Targeting Drugs Sales Market Share by Type (2027–2032)
Table 54. Global TYK2 Targeting Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global TYK2 Targeting Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global TYK2 Targeting Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global TYK2 Targeting Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global TYK2 Targeting Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global TYK2 Targeting Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global TYK2 Targeting Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global TYK2 Targeting Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global TYK2 Targeting Drugs Sales Market Share by Application (2021–2026)
Table 63. Global TYK2 Targeting Drugs Sales Market Share by Application (2027–2032)
Table 64. Global TYK2 Targeting Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global TYK2 Targeting Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global TYK2 Targeting Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global TYK2 Targeting Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global TYK2 Targeting Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global TYK2 Targeting Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bristol Myers Squibb TYK2 Targeting Drugs Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. InnoCare Company Information
Table 76. InnoCare Description and Business Overview
Table 77. InnoCare TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. InnoCare TYK2 Targeting Drugs Product
Table 79. InnoCare Recent Developments/Updates
Table 80. Takeda (Nimbus Therapeutics) Company Information
Table 81. Takeda (Nimbus Therapeutics) Description and Business Overview
Table 82. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product
Table 84. Takeda (Nimbus Therapeutics) Recent Developments/Updates
Table 85. Qiyuan Biotechnology Company Information
Table 86. Qiyuan Biotechnology Description and Business Overview
Table 87. Qiyuan Biotechnology TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Qiyuan Biotechnology TYK2 Targeting Drugs Product
Table 89. Qiyuan Biotechnology Recent Developments/Updates
Table 90. Inventisbio Company Information
Table 91. Inventisbio Description and Business Overview
Table 92. Inventisbio TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Inventisbio TYK2 Targeting Drugs Product
Table 94. Inventisbio Recent Developments/Updates
Table 95. Changzhou Hengbang Pharmaceutical Company Information
Table 96. Changzhou Hengbang Pharmaceutical Description and Business Overview
Table 97. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product
Table 99. Changzhou Hengbang Pharmaceutical Recent Developments/Updates
Table 100. Ventyx Biosciences Company Information
Table 101. Ventyx Biosciences Description and Business Overview
Table 102. Ventyx Biosciences TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Ventyx Biosciences TYK2 Targeting Drugs Product
Table 104. Ventyx Biosciences Recent Developments/Updates
Table 105. Galapagos NV Company Information
Table 106. Galapagos NV Description and Business Overview
Table 107. Galapagos NV TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Galapagos NV TYK2 Targeting Drugs Product
Table 109. Galapagos NV Recent Developments/Updates
Table 110. Oncostellae Company Information
Table 111. Oncostellae Description and Business Overview
Table 112. Oncostellae TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Oncostellae TYK2 Targeting Drugs Product
Table 114. Oncostellae Recent Developments/Updates
Table 115. BeiGene Company Information
Table 116. BeiGene Description and Business Overview
Table 117. BeiGene TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. BeiGene TYK2 Targeting Drugs Product
Table 119. BeiGene Recent Developments/Updates
Table 120. Sareum Holdings Pic Company Information
Table 121. Sareum Holdings Pic Description and Business Overview
Table 122. Sareum Holdings Pic TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sareum Holdings Pic TYK2 Targeting Drugs Product
Table 124. Sareum Holdings Pic Recent Developments/Updates
Table 125. Guangzhou Zaiji Pharmaceutical Company Information
Table 126. Guangzhou Zaiji Pharmaceutical Description and Business Overview
Table 127. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product
Table 129. Guangzhou Zaiji Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. TYK2 Targeting Drugs Distributors List
Table 133. TYK2 Targeting Drugs Customers List
Table 134. TYK2 Targeting Drugs Market Trends
Table 135. TYK2 Targeting Drugs Market Drivers
Table 136. TYK2 Targeting Drugs Market Challenges
Table 137. TYK2 Targeting Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of TYK2 Targeting Drugs
Figure 2. Global TYK2 Targeting Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global TYK2 Targeting Drugs Market Share by Type: 2025 & 2032
Figure 4. Single-target Inhibitors Product Picture
Figure 5. Dual-target Inhibitors Product Picture
Figure 6. Global TYK2 Targeting Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global TYK2 Targeting Drugs Market Share by Application: 2025 & 2032
Figure 8. Psoriasis
Figure 9. Systemic Lupus Erythematosus
Figure 10. Dermatitis
Figure 11. Arthritis
Figure 12. Others
Figure 13. Global TYK2 Targeting Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global TYK2 Targeting Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global TYK2 Targeting Drugs Sales (K Units), 2021–2032
Figure 16. Global TYK2 Targeting Drugs Average Price (US$/Unit), 2021–2032
Figure 17. TYK2 Targeting Drugs Report Years Considered
Figure 18. TYK2 Targeting Drugs Sales Share by Manufacturers in 2025
Figure 19. Global TYK2 Targeting Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global TYK2 Targeting Drugs Players: Market Share by Revenue in TYK2 Targeting Drugs in 2025
Figure 21. TYK2 Targeting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global TYK2 Targeting Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America TYK2 Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America TYK2 Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe TYK2 Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe TYK2 Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific TYK2 Targeting Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific TYK2 Targeting Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America TYK2 Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America TYK2 Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa TYK2 Targeting Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa TYK2 Targeting Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE TYK2 Targeting Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of TYK2 Targeting Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of TYK2 Targeting Drugs by Type (2021–2032)
Figure 56. Global TYK2 Targeting Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of TYK2 Targeting Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of TYK2 Targeting Drugs by Application (2021–2032)
Figure 59. Global TYK2 Targeting Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. TYK2 Targeting Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
